Medical Device News Magazine

PAN Foundation Launches COVID-19 Treatment and Prevention Fund to Help At-Risk Medicare Beneficiaries Pay for Treatment, Groceries and Other Critical Services

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

PAN Foundation, is an independent charitable organization dedicated to helping underinsured patients access critical medical care. Today they announced that it will offer financial assistance to Americans with existing medical conditions who have COVID-19 or are quarantined because of the virus.

Through this comprehensive fund, PAN will provide a $300 grant to qualifying Medicare beneficiaries with cancer, chronic or rare diseases who have also been diagnosed with COVID-19 or directed to self-quarantine by their healthcare provider or a government agency. Grant recipients can use the funds for treatment co-pays, prescription and over-the-counter medications, medical supplies and other important expenses related to COVID-19 prevention and treatment, including transportation to medical appointments and groceries, meals and food delivery services.

“The COVID-19 pandemic is a stark reminder of the importance of our mission to ensure that every American can afford the healthcare they need. While we don’t know the full impact of this outbreak, we’re dedicated to doing everything we can to protect and support the most vulnerable members of our society,” said PAN President and CEO Daniel J. Klein. “As Medicare beneficiaries and people with serious health conditions learn to cope with this rapidly evolving situation, we’re committed to providing assistance to help those who need it most so they can focus on getting better and worry less about the cost of care.”

The results of a recent poll by the Commonwealth Foundation highlight the collective worry of Americans about their ability to afford medical treatment: 68 percent of adults said that the out-of-pocket costs they might have to pay would be very or somewhat important in their decision to get treatment if they had symptoms of the coronavirus.

The COVID-19 Treatment and Prevention Fund is currently open for applicants who have annual household incomes up to 400 percent of the federal poverty level. Eligible patients can learn more about the fund on our website or by calling PAN at 1-866-316-7263 from Monday through Friday, 9 a.m. to 7 p.m. ET.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”